Nerve Transfer After Spinal Cord Injuries
Study Details
Study Description
Brief Summary
Nerve Transfer surgery can provide improved hand function following cervical spinal cord injuries
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Current treatment strategies of acute cervical spinal cord injuries remain limited. Treatment options that provide meaningful improvements in patient quality of life and long-term functional independence will provide a significant public health impact.
Specific Aim: Measure the efficacy of nerve transfer surgery in the treatment of patients with complete cervical spinal cord injuries with no hand function. Optimize the efficiency of nerve transfer surgery by evaluating patient outcomes in relation to patient selection and optimal timing the the surgery.
Hypothesis: Peripheral nerve transfers in patients with spinal cord injuries will improve hand function and provide improvement in patient quality of life and functional independence.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Nerve Transfer Surgical - Nerve transfers for patients with stable cervical spinal cord injuries |
Procedure: Nerve Transfer
A nerve transfer procedure will be individualized to each patient's functional deficit.
|
Outcome Measures
Primary Outcome Measures
- Change in upper motor strength [48 months]
Patients motor strength will be assessed over 48 months of clinical follow-up with conventional manual motor testing
Secondary Outcome Measures
- Change in Disabilities of Arm, Shoulder, and Hand (DASH) scores [48 months]
The change in DASH scores will be followed over time and assessed pre-operatively, 6,12, 18, 24, 36 and 48 months post-operatively.
- Change in Short Form 36 (SF-36) scores [48 months]
The change in SF-36 scores will be followed over time and assessed pre-operatively, 6, 12, 18, 24. 36 and 48 months post-operatively.
- Change in Michigan Hand Questionnaire (MHQ) [48 months]
The change in MHQ will be followed over time and assessed pre-operatively, 6, 12, 18, 24, 36 and 48 months post-operatively.
Other Outcome Measures
- Rates of Intraoperative and Post-operative complications [48 months]
The number of complications within and after the operation.
- Effect of timing on surgical intervention [48 months]
Assess the effect of timing on primary and secondary outcome measures, early (<12 months) vs. (>12 months)
- Rate of reoperation [48 months]
The rate at which a patient needs to be operated on again.
- Hand Function, measured by the Sollerman Hand Function Test [48 months]
The Sollerman Hand Function Test is performed as part of an overall evaluation and assessment by study team Occupational Therapist pre-operatively, post-operatively, and at 6 months, 12 months, 18 months, and 24 months. 36 months and 48 months
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18-65 years of age
-
Informed Consent Document (ICD) signed by patient
-
Cervical spinal cord injury resulting in arm & hand functional impairment, with at least preserved elbow function
-
International Classification of Surgery of the Hand in Tetraplegia (ICSHT) category 0
- 4
-
Patients with a stable American Spinal Injury Association (ASIA) grade of A, B, or C, or with a diagnosis of central cord syndrome, showing minimal to no evidence of functional improvement in motor examination after at least 6 months of non-operative therapy post-injury
-
Appropriate candidate for nerve transfer study
-
Willing and able to comply with the study protocol
-
< 48 months from injury
Exclusion Criteria:
-
Active infection at the operative site or systemic infection
-
Any return or ongoing clinical recovery of distal motor function within 6 months after injury
-
Physically or mentally compromised
-
Currently undergoing long-term steroid therapy
-
Significant joint contractures and/or limitations in passive range of motion in the arm or hand
-
Active malignancy
-
Systemic disease that would affect the patient's welfare or the research study
-
Pregnant
-
Immunologically suppressed or immunocompromised
-
Significant pain or hypersensitivity
-
Previous or current injury preventing use of tendon transfers to restore upper extremity function
-
Affective disorder of a degree that would make outcome assessment and study participation difficult
-
History of brachial plexus injury or systemic neuropathic process
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Washington University | Saint Louis | Missouri | United States | 63110 |
Sponsors and Collaborators
- Washington University School of Medicine
- United States Department of Defense
Investigators
- Principal Investigator: Wilson Z Ray, MD, Washington University School of Medicine
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- NTSCI -201208137